ENTINOSTAT: 123 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
123
Total FAERS Reports
51 (41.5%)
Deaths Reported
71
Hospitalizations
123
As Primary/Secondary Suspect
9
Life-Threatening
3
Disabilities
First Report: 20120913 · Latest Report: 20230501
What Are the Most Common ENTINOSTAT Side Effects?
#1 Most Reported
Infection
12 reports (9.8%)
#2 Most Reported
Anaemia
11 reports (8.9%)
#3 Most Reported
Death
10 reports (8.1%)
All ENTINOSTAT Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Infection | 12 | 9.8% | 10 | 0 |
| Anaemia | 11 | 8.9% | 3 | 5 |
| Death | 10 | 8.1% | 10 | 5 |
| Pyrexia | 9 | 7.3% | 4 | 8 |
| Abdominal pain | 8 | 6.5% | 0 | 7 |
| Disease progression | 8 | 6.5% | 8 | 0 |
| Sepsis | 8 | 6.5% | 6 | 5 |
| Thrombocytopenia | 8 | 6.5% | 3 | 2 |
| Fatigue | 7 | 5.7% | 0 | 3 |
| Diarrhoea | 6 | 4.9% | 1 | 4 |
| Febrile neutropenia | 6 | 4.9% | 2 | 3 |
| Hypotension | 6 | 4.9% | 1 | 6 |
| Asthenia | 5 | 4.1% | 0 | 3 |
| Confusional state | 5 | 4.1% | 3 | 4 |
| Dehydration | 5 | 4.1% | 1 | 4 |
| Dyspnoea | 5 | 4.1% | 2 | 4 |
| Hypokalaemia | 5 | 4.1% | 0 | 3 |
| Nausea | 5 | 4.1% | 0 | 2 |
| Neutropenia | 5 | 4.1% | 2 | 1 |
| Pleural effusion | 5 | 4.1% | 2 | 4 |
Who Reports ENTINOSTAT Side Effects? Age & Gender Data
Gender: 67.4% female, 32.6% male. Average age: 63.0 years. Most reports from: US. View detailed demographics →
Is ENTINOSTAT Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 2 | 0 | 1 |
| 2014 | 7 | 2 | 7 |
| 2015 | 5 | 2 | 3 |
| 2016 | 8 | 1 | 8 |
| 2017 | 11 | 3 | 8 |
| 2018 | 20 | 6 | 17 |
| 2019 | 27 | 6 | 23 |
| 2020 | 3 | 0 | 2 |
| 2022 | 2 | 0 | 0 |
| 2023 | 1 | 0 | 0 |
What Is ENTINOSTAT Used For?
| Indication | Reports |
|---|---|
| Renal cell carcinoma | 24 |
| Acute myeloid leukaemia | 21 |
| Breast cancer | 16 |
| Product used for unknown indication | 8 |
| Myelodysplastic syndrome | 7 |
| Adenocarcinoma pancreas | 5 |
ENTINOSTAT vs Alternatives: Which Is Safer?
ENTINOSTAT vs ENTRECTINIB
ENTINOSTAT vs ENZALUTAMIDE
ENTINOSTAT vs EPCORITAMAB
ENTINOSTAT vs EPCORITAMAB-BYSP
ENTINOSTAT vs EPERISONE
ENTINOSTAT vs EPHEDRINE
ENTINOSTAT vs EPINASTINE
ENTINOSTAT vs EPINEPHRINE
ENTINOSTAT vs EPINEPHRINE\LIDOCAINE
ENTINOSTAT vs EPIPEN
Official FDA Label for ENTINOSTAT
Official prescribing information from the FDA-approved drug label.